PIN44 COST-EFFECTIVENESS ANALYSIS OF 1 YEAR PEGINTERFERON ALFA-2A VERSUS 4 YEARS ENTECAVIR FOR THE TREATMENT OF HBEAG-POSITIVE CHRONIC HEPATITIS B IN CHINA

Nov 1, 2010, 00:00
10.1016/S1098-3015(11)72842-X
https://www.valueinhealthjournal.com/article/S1098-3015(11)72842-X/fulltext
Title : PIN44 COST-EFFECTIVENESS ANALYSIS OF 1 YEAR PEGINTERFERON ALFA-2A VERSUS 4 YEARS ENTECAVIR FOR THE TREATMENT OF HBEAG-POSITIVE CHRONIC HEPATITIS B IN CHINA
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)72842-X&doi=10.1016/S1098-3015(11)72842-X
First page : A438
Section Title : RESEARCH POSTER ABSTRACTS
Open access? : No
Section Order : 1000
Categories :
Tags :
Regions :
ViH Article Tags :